Fosun Pharmaceutical Selling Stake in Healthcare Firm for $124 Million

MT Newswires Live
03-14

Shanghai Fosun Pharmaceutical (SHA:600196) subsidiary Fosun Industrial plans to sell its stake in a hospital and clinic operator for $124.1 million, according to a Wednesday filing with the Shanghai bourse.

Fosun Industrial will transfer 9.4 million ordinary shares of the target company to Calcite Gem.

The deal, approved on Thursday, marks the company's exit from the parent company of Chinese medical service group Harmony Family.

The sale will generate about 650 million yuan in post-tax gains.

Shares of the company rose 1% in recent trade.

免责声明:投资有风险,本文并非投资建议,以上内容不应被视为任何金融产品的购买或出售要约、建议或邀请,作者或其他用户的任何相关讨论、评论或帖子也不应被视为此类内容。本文仅供一般参考,不考虑您的个人投资目标、财务状况或需求。TTM对信息的准确性和完整性不承担任何责任或保证,投资者应自行研究并在投资前寻求专业建议。

热议股票

  1. 1
     
     
     
     
  2. 2
     
     
     
     
  3. 3
     
     
     
     
  4. 4
     
     
     
     
  5. 5
     
     
     
     
  6. 6
     
     
     
     
  7. 7
     
     
     
     
  8. 8
     
     
     
     
  9. 9
     
     
     
     
  10. 10